Nbi Biosciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 3.80 Cr
- Company Age 5 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 200.00%
- Profit Growth -147.85%
- Ebitda -147.85%
- Net Worth 220.42%
- Total Assets 43.11%
About Nbi Biosciences
Nbi Biosciences Private Limited (NBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 04 November 2019 (Five years and two months 29 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.80 Cr, as per Ministry of Corporate Affairs (MCA) records.
Atul Kumar, Puneet Rathsharma, Bijender, and One other member serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U74999DL2019PTC356979
- Company No.
356979
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Nov 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Nbi Biosciences?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Atul Kumar  | Director | 04-Nov-2019 | Current |
| Puneet Rathsharma | Director | 30-Sep-2023 | Current |
| Bijender | Director | 17-Jun-2024 | Current |
| Anjali Kumar | Director | 04-Nov-2019 | Current |
Financial Performance of Nbi Biosciences.
Nbi Biosciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 200% increase. The company also saw a substantial fall in profitability, with a 147.85% decrease in profit. The company's net worth Soared by an impressive increase of 220.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nbi Biosciences?
In 2022, Nbi Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nbi Research Private LimitedAtul Kumar, Puneet Rathsharma and 2 more are mutual person
- Amrop India Consultants Private Limited
Anjali Kumar is a mutual person
- Amrop India Private Limited
Anjali Kumar is a mutual person
Nbi Elementals Private LimitedAtul Kumar, Bijender and 1 more are mutual person
- Btl Marketing Private Limited
Atul Kumar, Bijender and 1 more are mutual person
- Pravah Marketing Private Limited
Atul Kumar, Bijender and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nbi Biosciences?
Unlock and access historical data on people associated with Nbi Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nbi Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nbi Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
